India’s Bulk Drug Manufacturers Association (BDMA) will request that its government allow drug makers to switch product lines without applying for a new licence.
At present, it is mandatory for drug manufacturers to apply for a fresh licence each time they want to change formulations.
BDMA President M Narayana Reddy said that customers were switching to new drugs with extra features in a very short period, but official demands were resulting in a loss of time for firms.
“Change in a formulation will not increase the pollution load of a company,” said Reddy.
“Many bulk drug manufacturers are small-scale industries and it is not viable for them to adopt new processes continuously.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData